DHODH and cancer: In addition, AMPK agonists and DHODH inhibitors synergistically increase lipid ROS levels and induce ferroptosis in cancer cells, and low expression of the AMPK protein renders cancer cells more dependent on DHODH-mediated ferroptosis defenses99.